Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
Uwe ZeymerPeter LudmanTabassome SimonPetr KalaCécile LarocheMasoumeh SadeghiRoberto CaporaleSameh Mohamed ShaheenEwa Ł StępieńZaza IakobsishviliKhalid F AlhabibZuzana MotovskaMartin StudencanJorge MimosoDavid BeckerDimitrios AlexopoulosZviad KereseselidzeSinisa StojkovicParounak ZelveianArtan GodaErkin MirrakhimovGani BajraktariHasan Al-FarhanPranas ŠerpytisBent RaungaardToomas MarandiAlice May MooreMartin QuinnPasi Paavo KarjalainenGabriel Tatu-ChitoluChris P GaleAldo Pietro MaggioniFranz Weidingernull nullPublished in: European heart journal (2021)
The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- acute myocardial infarction
- st segment elevation myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- coronary artery disease
- cerebral ischemia
- coronary artery bypass grafting
- acute ischemic stroke
- healthcare
- coronary artery bypass
- blood brain barrier
- heart failure
- metabolic syndrome
- atrial fibrillation
- type diabetes
- emergency department
- combination therapy
- brain injury
- skeletal muscle
- weight loss